Francis specializes in health economics, health policy, econometrics and antitrust matters. For the health care industry, he specializes in the application of biostatistics, epidemiology, and the economics of health outcomes research. He has supported academic affiliates and has conducted and directed a wide range of investigations, including epidemiological evaluations, safety studies, pharmacovigilance, disease prediction modeling, assessment of direct and indirect cost of illness, and resource utilization patterns in the areas of cancer, chronic kidney disease, hypertension, hematology, HIV, cardiovascular disease, pulmonary disease and mental illness, among others. Through these investigations, he has collected and utilized data from clinical trials, electronic medical records, health insurance claims data and population-based surveys. His scientific research on various health topics has been published in peer-reviewed medical, health economics and managed care journals. It has also resulted in numerous presentations at national and international health care conferences as well as presentations to the Food and Drug Administration and the Centers for Medicare and Medicaid Services.
Francis has also contributed to the development of data driven decision-making models in various areas. Francis’s experience in antitrust matters includes quantifying the economic damages resulting from false advertising claims, and analyzing copyright infringement and unfair competition issues. Francis holds a B.A and a M.A. in Economics, with a specialization in Econometrics.